Cite
MLA Citation
Devalingam Mahalingam et al.. “374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A399. http://access.bl.uk/ark:/81055/vdc_100144724162.0x000004